Tauqeer Karim
About Tauqeer Karim
Tauqeer Karim is a Senior Medical Director with extensive experience in nephrology, drug safety, and clinical care outcomes research, currently holding multiple leadership roles in the pharmaceutical industry.
Current Positions
Tauqeer Karim holds multiple prominent roles in the medical and pharmaceutical industries. He is the Senior Medical Safety Advisor at 3 Analytics in Boston, Massachusetts. Additionally, he serves as the Senior Medical Director at Alkermes in Waltham, Massachusetts, and is the Vice President of Pharmacovigilance at SSI Strategy in the Greater Boston Area. He also works as a Senior Consultant Physician & Medical Safety Adviser at Symogen Inc in London, United Kingdom, and holds the position of President at Drug & Device Safety LLC in Waltham, MA. Furthermore, he is the Vice President and Drug & Device Safety Officer at Fresenius Medical Care North America in Waltham, MA, and the Medical Director of Global Patient Safety at Vertex Pharmaceuticals in Cambridge, MA.
Past Professional Experience
Tauqeer Karim has a rich history of contributions in various medical and research roles. He worked as an Associate Medical Director at Merck Research Laboratories from 2009 to 2010 and at Schering-Plough Pharmaceuticals from 2004 to 2010. Additionally, he was an Oakridge ORISE Research Fellow at the Office of Epidemiology & Biostatistics, CBER, from 2002 to 2003. Early in his career, he held significant medical officer roles within the United Arab Emirates Ministry of Health, including positions in nephrology and internal medicine departments.
Education and Training
Tauqeer Karim's educational background is robust, featuring diverse medical and research training. He earned his MBBS degree from Dow Medical College and studied various pre-medical sciences at Gordon College in Rawalpindi. He also obtained an MS in Clinical Care Research, Epidemiology, and Health Care Outcomes from Tufts University School of Medicine, as well as an MS in National Health Policy from The Heller School for Social Policy and Management at Brandeis University. Furthermore, he completed his post-doctoral graduate fellowship training at Tufts Medical School and served as an Oakridge Fellow at the FDA's Center for Biologics Evaluation and Research (CBER).
Specializations and Expertise
Tauqeer Karim specializes in several key areas within the medical field, including nephrology, hypertension, internal medicine, clinical care outcomes research, and epidemiology. He has expertise in evidence-based medicine, meta-analysis, drug safety surveillance, and signal detection. His career has focused on enhancing the pharmaceutical industry through continuous process improvement in clinical settings and providing clinical excellence. He has managed patients with kidney disease and has a strong background in drug safety and risk management.